Shandong Keyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
301281SZSE
Announcement of Resolutions from the 23rd Meeting of the 4th Board of Directors
✨ AI Summary
The 23rd meeting of the 4th Board of Directors of Shandong Keyuan Pharmaceutical Co., Ltd. approved the granting of restricted stock and changes to fundraising accounts. The board agreed to grant 600,000 shares of restricted stock to seven incentive targets on June 1, 2026. Additionally, the company will transfer funds from existing accounts to new accounts at different banks to enhance management efficiency. All decisions received unanimous approval.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.